Researchers compared the risk for serious infections in offspring of mothers with chronic inflammatory diseases who received non-TNFi biologics or tofacitinib during pregnancy vs offspring who were unexposed, but exposed to TNFi in utero.
Researchers sought to assess the ability of the Fracture Risk Assessment Tool to discriminate between women who do and do not experience major osteoporotic fractures.
Exceeding recommended doses of vitamins B6 and B12 may cause adverse effects such as hip fracture in postmenopausal women.
In a randomized control trial, researchers found that internet-delivered exposure therapy was more cost-effective for patients with fibromyalgia than a waitlist control, which did not involve any treatment during the experimental phase of the study.
Postmenopausal women have little awareness of osteoporotic fracture risk and poor understanding that a fragility fracture may be indicative of osteoporosis and that it increases future fracture risk.
The ACR/ ARHP created a rheumatology curriculum outline that can be used to create more efficient integration of NPs and PAs into rheumatology practice.
A 72-year-old Japanese woman with a 40-year history of lupus nephritis presented with leg edema that had lasted for several weeks.
A noninvasive test can be used to help monitor for risk of worsening fibrosis in psoriasis patients who have elevated hepatic steatosis.
About 40% of hospital patients reported breakdowns in care, for varying reasons.
Dalazatide treatment can improve skin lesions for patients with plaque psoriasis.
